Document is current
Any future updates will be listed below
-
Authors
Lazorwitz, Aaron https://orcid.org/0000-0003-0208-8432
Dindinger, Eva
Aguirre, Natasha
Sheeder, Jeanelle
- License Information
-
More Information
Article History
Received: 30 September 2019
Accepted: 14 December 2019
First Online: 21 December 2019
Compliance with ethical standards
:
: Dr. Aaron Lazorwitz has received research funding from Merck and Co. for an Investigator Initiated Study on drug–drug interactions with the etonogestrel contraceptive implant. The University of Colorado Department of Obstetrics and Gynecology has received research funding from Bayer, Agile Therapeutics, Sebela, Merck and Co, and Medicines360. Eva Dindinger has no conflicts of interest to disclose. Natasha Aguirre has no conflicts of interest to disclose. Jeanelle Sheeder has no conflicts of interest to disclose.
: This project was approved by the Colorado Multiple Institutional Review Board as a quality assessment project and the requirement for written informed consent was waived by our Institutional Review Board.
